IGKV1D-13 and type 2 diabetes mellitus: Further, the top-altered proteins, VPS13C, IGKV1D-13, and ADIPOQ can be used as biomarkers to detect high risk individuals or develop therapeutic targets to prevent the development of T2D in Ob-IR subjects.